ArticleMultiple sclerosis journal - experimental, translational and clinical

Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis.

Krista D DiSano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.